Jefferies Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,644
Closed -$446K 2027
2025
Q4
$446K Buy
+4,644
New +$451K ﹤0.01% 1365
2025
Q2
Sell
-6,762
Closed -$608K 1622
2025
Q1
$608K Sell
6,762
-118,737
-95% -$10.6M 0.01% 991
2024
Q4
$10M Buy
125,499
+11,703
+10% +$1.01M 0.06% 224
2024
Q3
$10.2M Buy
113,796
+76,675
+207% +$6.45M 0.07% 169
2024
Q2
$2.92M Hold
37,121
0.03% 439
2024
Q1
$3.24M Sell
37,121
-54,737
-60% -$4.67M 0.03% 429
2023
Q4
$7.57M Buy
91,858
+62,174
+209% +$4.74M 0.05% 289
2023
Q3
$2.33M Buy
+29,684
New +$2.48M 0.02% 577

Other funds holding MDT

Jefferies Financial Group's MDT Position: Q1 2026 in Review

Jefferies Financial Group sold out of Medtronic (MDT) in Q1 2026, closing a stake of 4,644 shares — an estimated $446K sold.

Jefferies Financial Group first reported a position in MDT in Q3 2023 and held it in 8 quarters. The position peaked at $10.2M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Jefferies Financial Group reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 4,644 Medtronic shares in Q1 2026, an estimated $446K.
  • Jefferies Financial Group first reported a position in Medtronic in Q3 2023 and held it in 8 quarters.
  • Jefferies Financial Group's Medtronic position peaked at $10.2M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.